Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model.

about

Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model.

Item

http://www.wikidata.org/entity/Q36266671

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Health economic evaluation of ...... lifetime Markov cohort model.

@ast

Health economic evaluation of ...... lifetime Markov cohort model.

@en

type

Item

label

Health economic evaluation of ...... lifetime Markov cohort model.

@ast

Health economic evaluation of ...... lifetime Markov cohort model.

@en

prefLabel

Health economic evaluation of ...... lifetime Markov cohort model.

@ast

Health economic evaluation of ...... lifetime Markov cohort model.

@en

P1476

Health economic evaluation of ...... a lifetime Markov cohort model

@en

P2093

Federico Augustovski

http://www.w3.org/2001/XMLSchema#string

Joaquín Enzo Caporale

http://www.w3.org/2001/XMLSchema#string

Jorge Alberto Gomez

http://www.w3.org/2001/XMLSchema#string

María Calderón

http://www.w3.org/2001/XMLSchema#string

Osvaldo Ulises Garay

http://www.w3.org/2001/XMLSchema#string

Paula Cortiñas

http://www.w3.org/2001/XMLSchema#string

Sebastián García Martí

http://www.w3.org/2001/XMLSchema#string

P2860

The causal relation between human papillomavirus and cervical cancer.

The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs

Long-term efficacy and safety of human papillomavirus vaccination

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study.

Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model

A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females.

P2888

s12889-017-4064-7

P304

152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12889-017-4064-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laura Naranjo

Marino J. Gonzalez

Ariel Bardach

Andrés Pichon Riviere

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083403156

http://www.w3.org/2001/XMLSchema#string

P698

28148228

http://www.w3.org/2001/XMLSchema#string

P932

5289055

http://www.w3.org/2001/XMLSchema#string